A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia

Anaesthesia. 2007 Sep;62(9):882-7. doi: 10.1111/j.1365-2044.2007.05173.x.

Abstract

We hypothesised that intramuscular halothane injection increases local Pco(2) concentrations in malignant hyperthermia susceptible (MHS) but not in non-susceptible (MHN) individuals. Pco(2) probes with attached microtubing catheters for halothane injection were placed into the lateral vastus muscle of eight MHS and eight MHN probands. Following equilibration, a single bolus of 200 microl halothane 5 and 6 vol% was injected. Pco(2) was measured spectrophotometrically. Baseline Pco(2) concentrations were similar between groups. Maximum Pco(2) and maximum rate of Pco(2) increase was significantly enhanced by halothane 5 and 6 vol% in MHS compared to MHN probands. Systemic haemodynamic and metabolic parameters did not differ between both groups. Local halothane application induces a hypermetabolic reaction with a significant Pco(2) increase in MHS compared to MHN probands, indicating a susceptibility to malignant hyperthermia. Intramuscular halothane injection with Pco(2) measurement seems to be a suitable method for the development of a minimally invasive metabolic test to diagnose malignant hyperthermia susceptibility.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anesthetics, Inhalation* / administration & dosage
  • Blood Pressure / drug effects
  • Carbon Dioxide / blood
  • Creatine Kinase / blood
  • Disease Susceptibility
  • Female
  • Halothane* / administration & dosage
  • Heart Rate / drug effects
  • Humans
  • Injections, Intramuscular
  • Male
  • Malignant Hyperthermia / blood
  • Malignant Hyperthermia / diagnosis*
  • Middle Aged
  • Myoglobin / blood
  • Partial Pressure

Substances

  • Anesthetics, Inhalation
  • Myoglobin
  • Carbon Dioxide
  • Creatine Kinase
  • Halothane